Snippet Search

Searching 12,176,221 documents.
Discover how a particular term or phrase is used in scientific literature

Showing 1 to 25 of 2953 matching articles

Results per page:

... a variety of human cancers containing the mutant  p53 
Establishment of ponasterone A-inducible the wild-type p53 protein-expressing clones from HSC-1 cells, cell growth suppression by p53 expression and the suppression mechanism
Establishment of ponasterone A-inducible the wild-type p53 protein-expressing clones from HSC-1 cells, cell growth suppression by p53 expression and the suppression mechanism
Hori, Makoto; Suzuki, Keiji; Udono, Masako U.; Yamauchi, Motohiro; Mine, Mariko; Watanabe, Masami; Kondo, Shigeo; Hozumi, Yutaka
(mt- ...
... conventional treatments and is often defective in  p53 
Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways
Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways
Shimazu, Kengo; Tada, Yuji; Morinaga, Takao; Shingyoji, Masato; Sekine, Ikuo; Shimada, Hideaki; Hiroshima, Kenzo; Namiki, Takao; Tatsumi, Koichiro; Tagawa, Masatoshi
pathways. ...
... Understanding the mechanism underlying  p53 
Simultaneous phosphorylation of p53 at serine 15 and 20 induces apoptosis in human glioma cells by increasing expression of pro-apoptotic genes
Simultaneous phosphorylation of p53 at serine 15 and 20 induces apoptosis in human glioma cells by increasing expression of pro-apoptotic genes
Amano, Toshiyuki; Nakamizo, Akira; Mishra, Sandip K.; Gumin, Joy; Shinojima, Naoki; Sawaya, Raymond; Lang, Frederick F.
’s ability to induce cell cycle arrest versus ...
... fate. Mutations within the TP53 (tumor suppressor  p53 
p53 regulates cytoskeleton remodeling to suppress tumor progression
p53 regulates cytoskeleton remodeling to suppress tumor progression
Araki, Keigo; Ebata, Takahiro; Guo, Alvin Kunyao; Tobiume, Kei; Wolf, Steven John; Kawauchi, Keiko
) gene leading to loss or gain of function (GOF) ...
... The tumor suppressor  p53 
The potential role of DFNA5, a hearing impairment gene, in p53-mediated cellular response to DNA damage
The potential role of DFNA5, a hearing impairment gene, in p53-mediated cellular response to DNA damage
Masuda, Yoshiko; Futamura, Manabu; Kamino, Hiroki; Nakamura, Yasuyuki; Kitamura, Noriaki; Ohnishi, Shiho; Miyamoto, Yuji; Ichikawa, Hitoshi; Ohta, Tsutomu; Ohki, Misao; Kiyono, Tohru; Egami, Hiroshi; Baba, Hideo; Arakawa, Hirofumi
plays a crucial role in the cellular response to ...
... we generated a series of Atm +/- mice on the  p53 
Atm heterozygous deficiency enhances development of mammary carcinomas in p53heterozygous knockout mice
Atm heterozygous deficiency enhances development of mammary carcinomas in p53heterozygous knockout mice
Umesako, Seiichi; Fujisawa, Kae; Iiga, Sayoko; Mori, Nobuko; Takahashi, Masahiro; Hong, Doo-Pyo; Song, Chang-Woo; Haga, Satomi; Imai, Syunsuke; Niwa, Otsura; Okumoto, Masaaki
+/- background with a certain predisposition to ...
... transduction. Furthermore, a role of the  p53 
Cytotoxic effects of replication-competent adenoviruses on human esophageal carcinoma are enhanced by forced p53 expression
Cytotoxic effects of replication-competent adenoviruses on human esophageal carcinoma are enhanced by forced p53 expression
Yang, Shan; Kawamura, Kiyoko; Okamoto, Shinya; Yamauchi, Suguru; Shingyoji, Masato; Sekine, Ikuo; Kobayashi, Hiroshi; Tada, Yuji; Tatsumi, Koichiro; Hiroshima, Kenzo; Shimada, Hideaki; Tagawa, Masatoshi
pathways in cytotoxicity mediated by ...
... In this work we present evidence that the  p53 
Modulation of p53 activity by IκBα: Evidence suggesting a common phylogeny between NF-κB and p53 transcription factors
Modulation of p53 activity by IκBα: Evidence suggesting a common phylogeny between NF-κB and p53 transcription factors
Dreyfus, David H; Nagasawa, Masayuki; Gelfand, Erwin W; Ghoda, Lucy Y
tumor suppressor protein and NF-κB transcription ...
... is the multifunctional transcription factor  p53 
p53 Replacement Therapy for Cancer
p53 Replacement Therapy for Cancer
Tazawa, Hiroshi; Kagawa, Shunsuke; Fujiwara, Toshiyoshi
gene that regulates diverse cellular phenomena ...
... studies have shown that aberrant activation of  p53 
Jmjd5 functions as a regulator of p53 signaling during mouse embryogenesis
Jmjd5 functions as a regulator of p53 signaling during mouse embryogenesis
Ishimura, Akihiko; Terashima, Minoru; Tange, Shoichiro; Suzuki, Takeshi
signaling leads to embryonic lethality. ...
... studies that the absence in cancer cells of the  p53 
Radiation induces p53-dependent cell apoptosis in bladder cancer cells with wild-type-p53 but not in p53-mutated bladder cancer cells
Radiation induces p53-dependent cell apoptosis in bladder cancer cells with wild-type-p53 but not in p53-mutated bladder cancer cells
Hinata, Nobuyuki; Shirakawa, Toshiro; Zhang, Zhujun; Matsumoto, Akira; Fujisawa, Masato; Okada, Hiroshi; Kamidono, Sadao; Gotoh, Akinobu
tumor suppressor gene, mutations of which are ...
... in regulation of the tumor suppressor  p53 
Rad9 modulates the P21WAF1pathway by direct association with p53
Rad9 modulates the P21WAF1pathway by direct association with p53
Ishikawa, Kazuhiro; Ishii, Hideshi; Murakumo, Yoshiki; Mimori, Koshi; Kobayashi, Masahiko; Yamamoto, Ken-ichi; Mori, Masaki; Nishino, Hiroshi; Furukawa, Yusuke; Ichimura, Keiichi
-dependent transactivation of pro-survival P21 ...
... To further elucidate the significance of  p53 
Intratumoral heterogeneous expression of p53 correlates with p53 mutation, Ki-67, and cyclin A expression in endometrioid-type endometrial adenocarcinomas
Intratumoral heterogeneous expression of p53 correlates with p53 mutation, Ki-67, and cyclin A expression in endometrioid-type endometrial adenocarcinomas
Feng, Yu-Zhen; Shiozawa, Tanri; Horiuchi, Akiko; Shih, Hsien-Chang; Miyamoto, Tsutomu; Kashima, Hiroyasu; Suzuki, Akihisa; Nikaido, Toshio; Konishi, Ikuo
mutation in endometrial carcinoma, we ...
... Wild-type sequence (wt)  p53 
CD4+ T cell responses to HLA-DP5-restricted wild-type sequence p53 peptides in patients with head and neck cancer
CD4+ T cell responses to HLA-DP5-restricted wild-type sequence p53 peptides in patients with head and neck cancer
Chikamatsu, Kazuaki; Sakakura, Koichi; Takahashi, Goro; Okamoto, Atsushi; Furuya, Nobuhiko; Whiteside, Theresa L.; DeLeo, Albert B.; Masuyama, Keisuke
peptides are attractive candidates for broadly ...
... the role of Chk2 using Molt-4 cells with  p53 
Checkpoint kinase 2 is dispensable for regulation of the p53 response but is required for G2/M arrest and cell survival in cells with p53 defects under heat stress
Checkpoint kinase 2 is dispensable for regulation of the p53 response but is required for G2/M arrest and cell survival in cells with p53 defects under heat stress
Furusawa, Yukihiro; Yamanouchi, Yuka; Iizumi, Takashi; Zhao, Qing-Li; Mitsuhashi, Yohei; Morita, Akinori; Enomoto, Atushi; Tabuchi, Yoshiaki; Kondo, Takashi
-targeted shRNA (Molt-4/shp53) and parental ...
... Background Although the presence of serum  p53 
Perioperative Changes of Serum p53 Antibody Titer is a Predictor for Survival in Patients with Esophageal Squamous Cell Carcinoma
Perioperative Changes of Serum p53 Antibody Titer is a Predictor for Survival in Patients with Esophageal Squamous Cell Carcinoma
Shimada, Hideaki; Shiratori, Tooru; Takeda, Akihiko; Matsushita, Kazuyuki; Okazumi, Shinichi; Akutsu, Yasunori; Matsubara, Hisahiro; Nomura, Fumio; Ochiai, Takenori
antibody (s- ...
... of the determinants of impaired chemosensitivity.  p53 
Does anti-p53 antibody status predict for clinical outcomes in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chemotherapy?
Does anti-p53 antibody status predict for clinical outcomes in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chemotherapy?
Osumi, Hiroki; Shinozaki, Eiji; Suenaga, Mitsukuni; Kumekawa, Yosuke; Ogura, Mariko; Ozaka, Masato; Matsusaka, Satoshi; Chin, Keisho; Yamamoto, Noriko; Mizunuma, Nobuyuki
is a tumor-suppressor protein in humans encoded ...
... the clinicopathological significance of the  p53 
Serum p53 antibody as a potential tumor marker in extrahepatic cholangiocarcinoma
Serum p53 antibody as a potential tumor marker in extrahepatic cholangiocarcinoma
Okada, Rei; Shimada, Hideaki; Otsuka, Yuichiro; Tsuchiya, Masaru; Ishii, Jun; Katagiri, Toshio; Maeda, Tetsuya; Kubota, Yoshihisa; Nemoto, Tetsuo; Kaneko, Hironori
protein expression and s- ...
... class II binding peptide from the tumor protein  p53 
Induction of tumor-reactive T helper responses by a posttranslational modified epitope from tumor protein p53
Induction of tumor-reactive T helper responses by a posttranslational modified epitope from tumor protein p53
Kumai, Takumi; Ishibashi, Kei; Oikawa, Kensuke; Matsuda, Yoshinari; Aoki, Naoko; Kimura, Shoji; Hayashi, Satoshi; Kitada, Masahiro; Harabuchi, Yasuaki; Celis, Esteban; Kobayashi, Hiroya
, which possesses an acetylated lysine at ...
... been shown to inactivate tumor suppressor protein  p53 
Mortalin-p53 Interaction as a Target for Liver Cancer Therapy
Mortalin-p53 Interaction as a Target for Liver Cancer Therapy
Lu, Wen-Jing; Lee, Nikki P.; Wadhwa, Renu; Luk, John M.
. ...
... oxygen species during wound repair responses.  p53 
SPRR2A enhances p53 deacetylation through HDAC1 and down regulates p21 promoter activity
SPRR2A enhances p53 deacetylation through HDAC1 and down regulates p21 promoter activity
Mizuguchi, Yoshiaki; Specht, Susan; Lunz, John G, III; Isse, Kumiko; Corbitt, Natasha; Takizawa, Toshihiro; Demetris, Anthony J
is also widely recognized as the node in cellular ...
... reductase (FDXR) is a putative contributor to  p53 
Gene expression of ferredoxin reductase predicts outcome in patients with metastatic colorectal cancer treated by 5-fluorouracil plus leucovorin
Gene expression of ferredoxin reductase predicts outcome in patients with metastatic colorectal cancer treated by 5-fluorouracil plus leucovorin
Ichikawa, Wataru; Ooyama, Akio; Toda, Etsuko; Sugimoto, Yoshikazu; Oka, Toshinori; Takahashi, Takehiro; Shimizu, Michio; Sasaki, Yasutsuna; Hirayama, Renzo
-mediated apoptosis from 5-fluorouracil (5-FU) ...
... analyses and found that several genes in the  p53 
Poly(ADP-ribose) polymerase inhibitors activate the p53 signaling pathway in neural stem/progenitor cells
Poly(ADP-ribose) polymerase inhibitors activate the p53 signaling pathway in neural stem/progenitor cells
Okuda, Akiko; Kurokawa, Suguru; Takehashi, Masanori; Maeda, Aika; Fukuda, Katsuya; Kubo, Yukari; Nogusa, Hyuma; Takatani-Nakase, Tomoka; Okuda, Shujiro; Ueda, Kunihiro; Tanaka, Seigo
signaling pathway were upregulated, including ...
... Although the preoperative serum level of  p53 
Peritherapeutic Serum p53 Antibody Titers are Predictors of Survival in Patients with Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemotherapy and Surgery
Peritherapeutic Serum p53 Antibody Titers are Predictors of Survival in Patients with Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemotherapy and Surgery
Yamashita, Kotaro; Makino, Tomoki; Tanaka, Koji; Yamasaki, Makoto; Yamamoto, Masaaki; Miyazaki, Yasuhiro; Takahashi, Tsuyoshi; Kurokawa, Yukinori; Nakajima, Kiyokazu; Takiguchi, Shuji; Mori, Masaki; Doki, Yuichiro
antibodies (s- ...
... serous adenocarcinoma. In these cases, the  p53 
Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases
Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases
Maeda, Daichi; Ota, Satoshi; Takazawa, Yutaka; Ohashi, Kenichi; Mori, Masaya; Imamura, Tetsuo; Nakagawa, Shunsuke; Yano, Tetsu; Taketani, Yuji; Fukayama, Masashi
immunophenotypes were similar in tubal lesions ...